La Jolla Pharmaceutical Co

CIK 920465 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for La Jolla Pharmaceutical Co.

Recent SEC filings

FiledFormAccession number
Feb 14, 2023SC 13G/A0000902664-23-001717
Sep 1, 202215-12G0000899140-22-000679
Aug 29, 2022SC 13D/A0000941560-22-000011
Aug 29, 2022SC 13D0000941560-22-000010
Aug 24, 202240001209191-22-047314
Aug 24, 202240000899243-22-029649
Aug 24, 202240000899243-22-029662
Aug 24, 202240000899243-22-029650
Aug 24, 202240000899243-22-029660
Aug 24, 202240000899243-22-029654
Aug 24, 202240000899243-22-029651
Aug 24, 202240000899243-22-029657
Aug 24, 2022SC 13D/A0001214659-22-010534
Aug 24, 202240000899243-22-029674
Aug 23, 2022S-8 POS0001564590-22-029988
Aug 23, 2022S-8 POS0001564590-22-029987
Aug 23, 2022S-8 POS0001564590-22-029991
Aug 23, 2022S-8 POS0001564590-22-029990
Aug 23, 2022S-8 POS0001564590-22-029989
Aug 22, 2022SC TO-T/A0001193125-22-226088
Aug 22, 2022SC 14D9/A0001193125-22-226104
Aug 22, 202225-NSE0001354457-22-000471
Aug 22, 20228-K0001193125-22-226110
Aug 16, 2022SC TO-T/A0001193125-22-222390
Aug 15, 2022SC 14D9/A0001193125-22-220630